Stay updated on Pediatric Galcanezumab for Episodic Migraine Clinical Trial

Sign up to get notified when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide NIH banner announces a transition in terminology, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.2%
    Check dated 2026-10-25T13:11:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The website footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-18T14:31:46.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-11T14:42:58.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page footer's Revision label updates from v3.6.6 to v3.7.0, indicating a new site version for the Study Record History page.
    Difference
    0.0%
    Check dated 2026-09-20T20:20:36.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A new Revision: v3.6.6 appears in the history. The previous Revision: v3.6.5 is removed.
    Difference
    0.0%
    Check dated 2026-08-30T21:55:26.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The history now shows a new Revision: v3.6.5 entry replacing the previous v3.6.4, indicating a backend update to the page’s history log.
    Difference
    0.0%
    Check dated 2026-08-09T11:16:27.000Z thumbnail image

Stay in the know with updates to Pediatric Galcanezumab for Episodic Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.